MyFinsight
Home
Blog
About
Net loss
-$14,876K
(-60.25%↓ Y/Y)
Loss from continuing
operations
-$8,659K
(loss) income from
discontinued operations
-$6,217K
Loss before income
taxes from continuing...
-$8,659K
(6.72%↑ Y/Y)
US
$29,552K
(-47.31%↓ Y/Y)
GB
$7,330K
(2.33%↑ Y/Y)
Operating loss
-$5,441K
(57.46%↑ Y/Y)
Total other (expense)
income
-$3,218K
(-191.79%↓ Y/Y)
Revenues
$36,882K
(-41.69%↓ Y/Y)
Foreign currency loss
(gain)
$165K
(-96.97%↓ Y/Y)
Total costs and
expenses
$42,323K
(-44.34%↓ Y/Y)
Interest expense, net
-$2,281K
(-17.40%↓ Y/Y)
Loss on investments
-$1,102K
Partner share and other
third-party costs
$15,614K
(-42.39%↓ Y/Y)
General and
administrative expense
$7,855K
(-39.13%↓ Y/Y)
Sales and marketing
expense
$6,605K
(-41.73%↓ Y/Y)
Research and development
expense
$5,540K
(-50.95%↓ Y/Y)
Depreciation and
amortization expense
$4,061K
(-35.28%↓ Y/Y)
Delivery costs
$2,648K
(-61.53%↓ Y/Y)
Back
Back
Income Statement
Cardlytics, Inc. (CDLX)
Cardlytics, Inc. (CDLX)
source: myfinsight.com